TGA Approval

ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle (407150)

ARTG ID

407150

ARTG Name

ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle

Sponsor

Glenmark Pharmaceuticals Australia Pty Ltd

ARTG Date

April 9, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

GLENMARK PHARMACEUTICALS (AUSTRALIA) PTY LIMITED

https://medical-cdn.nocode.com/drug_tga/0a8c94fd771d2fe2ceb8750cd2c1b5d5.pdf

https://medical-cdn.nocode.com/drug_tga/2da1cd2e7a53e94925b392a2d432b955.pdf

Ingredient Name

atovaquone

Empowering clinical research with data-driven insights and AI-powered tools.

ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottle (407150) - TGA 批准文号 | MedPath